SCHEMBL21023409

SCHEMBL21023409

CC(C)CC(C)N(C)Cc1ccc(C(C)(C)C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.43
SLC6A2 P23975 2/20 0.43
HTR2A P28223 2/20 0.43
SLC6A4 P31645 2/20 0.43
ADRA2B P18089 2/20 0.43
ADRA2C P18825 2/20 0.43
ADRA1A P35348 2/20 0.43
OPRK1 P41145 1/20 0.43
SLC6A3 Q01959 1/20 0.43
TP53 P04637 2/20 0.41
TSHR P16473 1/20 0.41
ADRA2A P08913 2/20 0.40
LMNA P02545 2/20 0.40
NR1I2 O75469 1/20 0.40
CYP2D6 P10635 1/20 0.40
ACHE P22303 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
GRIA4 P48058 1/20 0.36
PYCR1 P32322 1/20 0.36
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7037591 0.79 NR4A2 (0.44) TP53TSHRLMNASIGMAR1EPHX1
SCHEMBL7037587 0.79 NR4A2 (0.44) TP53TSHRLMNASIGMAR1EPHX1
SCHEMBL13995227 0.78 ADRA2B (0.69) KCNH2SLC6A2HTR2ASLC6A4ADRA2B
SCHEMBL13995599 0.78 ADRA2B (0.69) KCNH2SLC6A2HTR2ASLC6A4ADRA2B
SCHEMBL13995597 0.78 ADRA2B (0.69) KCNH2SLC6A2HTR2ASLC6A4ADRA2B
SCHEMBL7369137 0.74 MEN1 (0.38) TP53TSHRLMNAALDH1A1EPHX1
SCHEMBL7369135 0.74 MEN1 (0.38) TP53TSHRLMNAALDH1A1EPHX1
SCHEMBL798094 0.73 HRH3 (0.58) KCNH2SLC6A2HTR2ASLC6A4ADRA2B
SCHEMBL8902822 0.73 KCNH2 (0.44) KCNH2SLC6A2HTR2ASLC6A4ADRA2B
SCHEMBL8053786 0.71 KCNH2 (0.46) KCNH2SLC6A2HTR2ASLC6A4ADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3485881-A1 PERMANENTLY CHARGED SODIUM AND CALCIUM CHANNEL BLOCKERS AS ANTI-INFLAMMATORY AGENTS President and Fellows of Harvard College (US) 2019-05-22 EP disclosed